UTHR
UNITED THERAPEUTICS CorpCompany with tickers: UTHR
CIK
1082554
CUSIP
91307C102
Shares Outstanding
42,446,733
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $794,400,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | — | ||||
| Gross Profit | $701,900,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Operating Expenses | — | ||||
| Research & Development | $149,000,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $382,800,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Net Income | $322,200,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $7.18 | USD/shares | 2025-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $6.63 | USD/shares | 2025-03-31 | 10-Q | 2026-05-06 |